A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009
A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009
复制标题
DOI：
10.1093/jac/dks445
复制
发表时间：
2013-03-01
影响因子：
5.2
通讯作者：
Danziger, Larry H.
中科院分区：
文献类型：
--
作者：
Suda, Katie J.;Hicks, Lauri A.;Danziger, Larry H.
促进适当的抗生素使用有可能通过减少不必要的处方和耐药感染的发生率来降低医疗成本。然而，人们对美国医疗保健系统中抗生素成本的产生知之甚少。我们评估了美国医疗机构和抗生素类别的抗生素支出。2009年的系统性抗生素支出摘自IMS Health（c）国家销售展望数据库。这些数据代表了2009年1月1日至2009年12月31日美国所有药物购买的统计有效预测。抗生素支出总计107亿美元。大部分支出（61.5%）与门诊有关，特别是来自社区药房。住院和长期护理机构分别占支出的33.6%和4.9%。占抗生素总支出最多的抗生素类别是喹诺酮类，其次是青霉素类。2009年美国用于抗生素治疗的费用超过107亿美元。不同医疗机构的抗生素支出存在差异，其中大部分在门诊，其中87例在社区药房。
Promoting appropriate antibiotic use has the potential to decrease healthcare costs by reducing unnecessary prescriptions and the incidence of resistant infections. However, little is known about where antibiotic costs are incurred in the US healthcare system. We evaluated antibiotic expenditures by healthcare setting and antibiotic class in the USA.Systemic antibiotic expenditures in 2009 were extracted from the IMS Health (c) National Sales Perspectives database. These data represent a statistically valid projection of all medication purchases in the USA from 1 January 2009 to 31 December 2009.Antibiotic expenditures totalled $10.7 billion. The majority (61.5) of expenditures were associated with the outpatient setting, especially from community pharmacies. Inpatient and long-term care settings accounted for 33.6 and 4.9 of expenditures, respectively. The class of antibiotics that accounted for the most antibiotic expenditure overall was the quinolones, followed by the penicillins.Over $10.7 billion was spent in 2009 on antibiotic therapy in the USA. Differences were observed in antibiotic expenditures by healthcare setting, with the majority in the outpatient setting, 87 of which was in community pharmacies.